ESC 2015: ‘Shocking’ Outcomes Of Sleep Apnea-Heart Failure Trial Spell Gloom For ResMed
Executive Summary
Results from the SERVE-HF trial, presented at the recent European Society of Cardiology meeting and published in the NEJM, showed systolic heart failure patients with central sleep apnea treated with adaptive servo-ventilation actually had worse mortality outcomes than the control group. These results "shocked " both the respiratory and cardiology community and spell gloom for ResMed's sleep apnea therapy.